Minimally Invasive Surgery Market Size & Forecast, 2025-2032

Minimally Invasive Surgery Market Analysis & Forecast

Minimally Invasive Surgery Market size is estimated to be valued at USD 89,393.7 Mn in 2025 and is expected to reach USD 1,85,595.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 11% from 2025 to 2032.

Key Takeaways

By Device Type, The Surgical Devices Segment is projected to dominate the global minimally invasive surgery market outlook with a 55% share over the forecast period, owing to the rising demand for precision tools and advanced instrumentation in minimally invasive procedures.
By Region, North America is expected to lead the market with a 43.2% share, driven by high adoption of robotic-assisted surgeries, strong healthcare infrastructure, and ongoing investments in surgical innovation.

Market Overview

The Minimally Invasive Surgery (MIS) market value is experiencing robust growth, driven by the increasing demand for procedures that offer reduced trauma, quicker recovery, and lower complication risks compared to traditional open surgeries. Usage of minimally invasive surgery for the treatment of major chronic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period.

For instance, the adoption of minimally invasive transcatheter aortic valve replacement (TAVR) has significantly increased for patients with severe aortic stenosis. According to the American College of Cardiology, as of 2025, over 80% of eligible elderly patients in the U.S. are now treated with TAVR rather than open-heart surgery, owing to its advantages in minimizing postoperative complications and expediting recovery—highlighting a clear trend toward MIS in chronic disease management.

Current Events and Its Impact on the Minimally Invasive Surgery (MIS) Market

Event	Description and Impact
EU Medical Device Regulations (MDR) Implementation	Description: Stricter Compliance Requirements for instance, In 2024, several SMEs in Europe reported delays exceeding six months in obtaining MDR certification due to increased documentation and quality management system (QMS) upgrade demands, impacting their product launch timelines. Impact: Higher costs for QMS upgrades, extended approval timelines, and increased documentation demands, particularly affecting SMEs. Description: Impact on Small Manufacturers for instance, a 2025 survey by MedTech Europe found that over 40% of small medical device manufacturers struggled to allocate resources for ongoing clinical evaluations and post-market surveillance, delaying their entry into the EU market. Impact: Challenges in resource allocation for clinical evaluations and post-market surveillance, potentially slowing market entry.
FDA AI Integration for Regulatory Reviews	Description: Accelerated Approval Processes. For instance, The FDA’s pilot program using AI to review clinical data for minimally invasive surgery devices reduced average review time by 30% in 2024, speeding up time-to-market for innovative surgical tools. Impact: AI-driven efficiency in data synthesis and summaries to reduce review times for MIS devices. Description: Enhanced Data Analysis. For instance, In late 2024, AI-powered algorithms enabled the FDA to detect subtle safety signals in MIS device submissions that traditional methods had missed, enhancing regulatory decision accuracy. Impact: Improved accuracy in evaluating clinical and safety data for submissions.
Global Supply Chain Disruptions	Description: U.S. Medical Device Shortages. For instance, In September 2024, Hurricane Helene caused a temporary shutdown of a key IV fluid manufacturing plant in the U.S., leading to shortages that affected availability of associated minimally invasive surgical kits nationwide. Impact: Concentrated manufacturing vulnerabilities (e.g., Hurricane Helene impacting IV fluid production) disrupting surgical tool availability. Description: China Export Restrictions. For instance, In 2025, Western medical device companies faced supply constraints after Chinese authorities blacklisted Illumina, a critical supplier of gene sequencing components, disrupting global device manufacturing workflows. Impact: Trade barriers and blacklisting (e.g., Illumina) limiting Western companies’ access to critical components and markets.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Pipeline Analysis – Minimally Invasive Surgery (MIS) Market

The minimally invasive surgery space now centers on fresh hardware-surgical gadgets, smart robotics, and sharp imaging-rather than drugs. Intuitive Surgical pushes robotic arms that pair AI with 3D views, LSI Solutions builds self-stitching tools, Ethicon offers electrosurgical and vessel-sealing gear,

Tendyne supplies transcatheter mitral valves, and Invuity shines light-based cameras into endoscopes. From 2023 to 2025, more than 40 percent of new patents cover robotic systems that forecast moves, 30 percent upgrade cameras to 4K or 8K with AR overlays, and 15 percent tweak designs to make them single-use and compostable.

Together, these filings show a swing toward pinpoint accuracy, eco-minded parts, and on-the-spot pictures for surgeons. Analysts expect the global market for MIS devices to swell at an 8.7 percent compound annual growth rate, hitting 65.1 billion dollars by 2032. Most products are following quick FDA 510(k) lanes, while large-scale robotic suites sit near the finish line. Drug-coated tools still exist but occupy a tiny corner of the pipeline, leaving the device race mostly hardware-driven.

Patent Landscape – Minimally Invasive Surgery (MIS) Market

The patent picture for minimally invasive surgery shows a lively wave of ideas, mostly packed into surgical robots, sharper cameras, and smart handheld tools. Between 2023 and 2025 filings shot upward in the United States, Europe, and Asia, proof that hospitals want ever more precise procedures. Robots still take the lead; more than forty percent of recent applications claim AI brains, tiny mechanics, and finer steering.

Intuitive Surgical, Johnson & Johnsons Ethicon group, and Medtronic hold the lion share, betting big on plug-and-play platforms and comfy grips. Patents for imaging make up roughly thirty percent, aiming at clearer lenses, augmented-reality overlays, and on-the-table display helpers. Greener practice is surfacing too, with fifteen percent of European filings touting recyclable or less wasteful single-use tools.

Add sensor-packed instruments and cordless patient monitors, and the picture turns smart, hinting at next-gen MIS suites. All told, this patent scene proves a fast-moving contest where blended technologies keep pushing surgical care into tighter, safer spaces.

Reimbursement Scenario – Minimally Invasive Surgery (MIS) Market

Minimally invasive surgery (MIS) sits inside a fast-changing-but-often-baffling billing world shaped by codes, rules, and each insurers special quirks. New Category I CPT codes for Endoscopic Submucosal Dissection, set to debut in January 2027, aim to clear up payment gaps for advanced GI work. Medicare groups nearly all surgery-related care into global bundles that cover time before, during, and after the procedure-usually set at 0, 10, or 90 days. Most laparoscopic cases land in the 90-day bucket, meaning follow-up care shows up in the original bill. Pain control, much split/shared work, and other routine after-care sit inside that package, so practices cannot charge for them again.

The Centers for Medicare & Medicaid Services writes the global surgery rules, while the American Medical Association creates the CPT line items. Insurers such as Moda Health mostly mirror Medicares playbook, tweaking a rule here and there. State Medicaid plans usually trail Medicare as well, although some set their own fee schedules. In-network private carriers tend to pay 80 to 100 percent of the agreed rate, yet they let offices self-submit charges once the 90-day window closes.

Hold-ups still happen because new MIS techniques lack dedicated codes or because prior authorization adds red tape. Nonetheless, the coming ESD designation-and similar future efforts-should lift payment certainty and encourage wider adoption of truly minimally invasive approaches.

Prescribers’ Preference – Minimally Invasive Surgery (MIS) Market

Minimally invasive surgery (MIS) wins praise from clinicians for easing pain, speeding recovery, cutting complications, and leaving patients happier. Still, every use rests on how well a procedure works, who the patient is, and the latest tools on hand. Treatment lines by surgery type

Gastrointestinal & Abdominal: laparoscopic cholecystectomy keeps its place as the go-to way to take out the gallbladder. Hernia fixes lean on transabdominal preperitoneal (TAPP) or totally extraperitoneal (TEP) methods Bariatric options, such as sleeve gastrectomy, help patients facing severe obesity.
Spinal Surgery: MIS transforaminal lumbar interbody fusion (MIS-TLIF) and lateral routes (XLIF/DLIF) spare more muscle and ligament.
Orthopedics: arthroscopic repairs of shoulder and knee rank high for common joint complaints. Disease stage matters: early issues suit gentle work such as laparoscopic cholecystectomy for symptomatic gallstones, while later stages call for heavier lifts such as MIS-TLIF or a Roux-en-Y gastric bypass.
Perioperative medicines: prophylactic antibiotics, low-dose antithrombotics before surgery, strong local blocks and mild sedatives during, and NSAIDs with brief opioids after all stack the odds in favor of smooth healing.
Influencing factors: the surgeon’s skill, a patient’s age and BMI, robot arms or better imaging on standby, and tight budgets together steer what is chosen.
Emerging trends: techniques like natural-orifice transluminal endoscopic surgery (NOTES) or single-incision laparoscopy excite some teams even though learning curves remain steep. Overall, the MIS toolbox keeps growing as evidence, tech push, and patient demand collide.

Segmental Insights

Minimally Invasive Surgery Market By Device Type

To learn more about this report, Request sample copy

Minimally Invasive Surgery Market Insights, By Device Type

The surgical devices segment is expected to dominate with 55.0% share of the global minimally invasive surgery market over the forecast period. This segment includes ablation devices, electrosurgical devices, and medical robotic systems. The segment’s leading position is primarily driven by the growing use of endoscopy devices, which are integral to various minimally invasive procedures due to their ability to provide high-resolution imaging and precise navigation in confined anatomical areas. The expanding adoption of robotic-assisted surgical systems is further reinforcing the demand for advanced surgical tools, particularly in complex surgeries that require enhanced dexterity and precision.

Meanwhile, the monitoring & visualization devices and endoscopy devices segments are also poised for significant growth. These devices play a crucial role in enhancing procedural accuracy and minimizing intraoperative risks. Innovations in imaging technologies, such as 3D visualization and high-definition optics, are reshaping intraoperative guidance, making them indispensable tools for modern minimally invasive interventions.

Minimally Invasive Surgery Market Insights, By Surgery

Among surgical types, the cardiac surgery segment is expected to lead the global minimally invasive surgery market throughout the forecast period. This dominance is attributed to the rising global prevalence of cardiac disorders, which is fueling the demand for less invasive alternatives to conventional open-heart surgeries. Minimally invasive cardiac procedures offer the benefits of shorter recovery times, fewer complications, and reduced hospital stays, making them increasingly preferred by both patients and healthcare providers.

The orthopedic surgery segment is also projected to witness substantial growth over the coming years. The growing burden of musculoskeletal conditions, particularly osteoarthritis among the elderly population, is a key driver. For example, according to the World Health Organization, a significant portion of the global population aged 60 years and older suffers from osteoarthritis, contributing to a higher volume of joint replacement and repair procedures using minimally invasive techniques.

With the increasing application of MIS across other specialties such as gynecological, gastrointestinal, and cosmetic surgery, the surgery segment as a whole presents the highest potential to propel market growth, as healthcare systems increasingly prioritize procedures that reduce trauma and enhance patient outcomes.

Global Minimally Invasive Surgery Market- Regional Insights

Minimally Invasive Surgery Market Regional Insights

To learn more about this report, Request sample copy

North America Minimally Invasive Surgery Market Analysis and Trends

North America is projected to dominate with 43.20% share of the global minimally invasive surgery market over the forecast period, supported by the region’s advanced healthcare infrastructure, strong adoption of innovative surgical technologies, and rising prevalence of chronic diseases—particularly cardiovascular conditions. The U.S., in particular, continues to lead in the use of robotic-assisted and image-guided minimally invasive procedures, driven by patient demand for faster recovery and lower procedural risks.

According to the New York State Department of Health (August 2025), approximately 697,000 people in the U.S. die from cardiac disease annually, underscoring a significant need for less invasive cardiac interventions. These high disease burdens, coupled with increasing investments in surgical innovation and training, are reinforcing North America’s leading position in the market. However, market growth in the region may be moderated by high procedural and device costs, as well as regulatory complexities.

Global Minimally Invasive Surgery: Market Dynamics

Increasing Prevalence of Orthopedic Diseases

Increasing prevalence of orthopedic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in July 2022, according to World Health Organization (WHO), approximately 1.71 billion people have musculoskeletal conditions worldwide.

Global Minimally Invasive Surgery Market: Key Trends

Increasing Number of Cardiac Surgeries

Increasing number of cardiac surgeries is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in June 2022, according to an article published by National Institute of Health, more than 2 million people underwent open-heart surgery to treat various heart problems worldwide, every year.

Global Minimally Invasive Surgery Market: Restraint

Disadvantages Associated with Minimally Invasive Surgery

Global minimally invasive surgery market growth can be hindered by disadvantages associated with minimally invasive surgery. For instance, in October 2020, according to Spine Institute of North America, a leading spine and pain specialist, the main disadvantage of minimally invasive surgery is that it requires a higher level of training, and thus, insufficient training can lead to complications such as perforation of the gallbladder, biliary leak, bile duct injury, biliary stricture, etc.

Hence, reducing the disadvantages associated with minimally invasive surgery will assess in the growth of the global minimally invasive surgery market.

Market Report Scope

Minimally Invasive Surgery Market Report Coverage

Report Coverage	Details
Base Year:	2024	Market Size in 2025:	USD 89,393.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11%	2032 Value Projection:	USD 1,85,595.6 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Device Type: Surgical Devices, Ablation Devices, Electrosurgical Devices, Medical Robotic Systems, Monitoring & Visualization Devices, Endoscopy Devices By Surgery: Orthopedic Surgery, Cosmetic Surgery, Breast Surgery, Vascular Surgery, Thoracic Surgery, Gynecological Surgery, Bariatric Surgery, Cardiac Surgery, Gastrointestinal Surgery, Urological Surgery
Companies covered:	Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, and Integrated Endoscopy
Growth Drivers:	Increasing prevalence of orthopedic diseases
Restraints & Challenges:	Disadvantages associated with minimally invasive surgery

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Global Minimally Invasive Surgery Market- Cross Sectional Analysis

In surgery, cardiac surgery held a dominant segment in North America region due to increasing prevalence of cardiac disorders. For instance, in July 2020, according to Healthline Media LLC, a consumer health publisher, about 647,000 people die due to cardiac disease every year that makes it the leading cause of death in the U.S.

Analyst Viewpoint

The global minimally invasive surgery (MIS) market is being propelled by the increasing burden of chronic diseases, notably cardiovascular and orthopedic conditions that require surgical intervention.
Technological breakthroughs—particularly in robotic platforms, AI integration, and real-time imaging—are driving higher adoption by enhancing surgical precision and broadening the scope of treatable conditions.
Strategic government programs, such as Horizon Europe and U.S. innovation grants, are accelerating surgical infrastructure upgrades and R&D investments in advanced MIS technologies.
Barriers to growth include high capital costs of robotic systems, integration challenges within existing hospital workflows, and limited reimbursement schemes, especially in emerging regions.
The steep learning curve for surgeons adopting complex MIS platforms continues to slow adoption rates in some settings.
Outpatient surgical centers present a major growth opportunity, driven by rising patient preference for faster recovery and reduced hospital stays.
Asia-Pacific is rapidly emerging as a high-growth region, supported by medical tourism, aging demographics, and increasing public-private investments in surgical modernization.
The future of MIS will likely be shaped by nanotechnology, remote robotic surgeries, and AI-enabled procedural planning, with North America maintaining dominance through innovation and early technology integration.

Global Minimally Invasive Surgery Market- Key Developments

In May 2025, Intuitive Surgical announced a next-generation upgrade to its da Vinci robotic system with enhanced tactile feedback and AI-assisted navigation, targeting complex thoracic and urologic procedures.
In March 2025, CMR Surgical expanded the global rollout of its Versius robotic platform into Latin America and Southeast Asia, aiming to capture emerging market demand for compact, cost-effective MIS solutions.
In February 2025, Johnson & Johnson’s Ethicon division received FDA clearance for its powered laparoscopic stapler with integrated real-time tissue sensing, improving precision and reducing intraoperative errors.
In December 2024, the U.K.’s National Health Service (NHS) announced a strategic initiative to scale robotic-assisted surgeries from 70,000 to 500,000 annually by 2035, supported by additional public funding and training programs.
In October 2024, Medtronic launched a VR-based surgical training suite in collaboration with major teaching hospitals in Europe to address the growing need for skilled MIS practitioners amid rapid technology adoption.

Market Segmentation

Global Minimally Invasive Surgery Market, By Device Type
- Surgical Devices
  - Ablation Devices
  - Electrosurgical Devices
  - Medical Robotic Systems
- Monitoring & Visualization Devices
- Endoscopy Devices

Global Minimally Invasive Surgery Market, By Surgery
- Orthopedic Surgery
- Cosmetic Surgery
- Breast Surgery
- Vascular Surgery
- Thoracic Surgery
- Gynecological Surgery
- Bariatric Surgery
- Cardiac Surgery
- Gastrointestinal Surgery
- Urological Surgery
Global Minimally Invasive Surgery Market, By Region
- North America
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Blood Stream Infections
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Cosmetic Surgery
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Cosmetic Surgery
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Cosmetic Surgery
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Cosmetic Surgery
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Device Type
    - Surgical Devices
      - Ablation Devices
      - Electrosurgical Devices
      - Medical Robotic Systems
    - Monitoring & Visualization Devices
    - Endoscopy Devices
  - By Surgery
    - Orthopedic Surgery
    - Cosmetic Surgery
    - Breast Surgery
    - Vascular Surgery
    - Thoracic Surgery
    - Gynecological Surgery
    - Bariatric Surgery
    - Cardiac Surgery
    - Gastrointestinal Surgery
    - Urological Surgery
  - By Country/Region
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Abbott
- ArthroCare Corporation
- Integer Holdings Corporation
- Zimmer Biomet
- DePuy Synthes, Inc.
- Conmed Corporation
- GE Healthcare
- Given Imaging Ltd.
- Intuitive Surgical, Inc.
- Medtronic, plc.
- NuVasive, Inc.
- Philips Healthcare
- InMode Ltd.
- Titan Medical Inc.
- Fractyl Inc.
- Biom’up SA
- Integrated Endoscopy

Sources

Primary Research Interviews

Leading MIS surgeons specializing in robotic-assisted procedures
Medical device R&D heads from key market players
Hospital administrators from AMC-ranked healthcare facilities
Healthcare policy analysts from G20 nations
Others

Databases

WHO Global Health Observatory
CMS Hospital Cost Report Information System
OECD Health Statistics 2024
Others

Magazines

Medical Product Outsourcing Magazine
Becker's Hospital Review
The Surgeon's Journal
Others

Journals

Journal of Minimally Invasive Surgery
Surgical Endoscopy
Annals of Laparoscopic and Endoscopic Surgery
Others

Newspapers

Healthcare Business Today
MedTech Dive
The New England Journal of Medicine Catalyst
Others

Associations

Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
International Federation for the Surgery of Obesity (IFSO)
American Association of Thoracic Surgery (AATS)
Others

Public Domain Sources

WHO Noncommunicable Diseases Progress Monitor 2025
CDC National Hospital Discharge Survey
European Commission Medical Device Regulation Portal
Others

Proprietary Elements

CMI Data Analytics Tool
Proprietary CMI Existing Repository of Information for Last 8 Years

About Author

Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.

Missing comfort of reading report in your local language? Find your preferred language :

Transform your Strategy with Exclusive Trending Reports :

Sterilization Equipment And Disinfectants Market

Sports Medicine Devices Market

Active Implantable Medical Devices Market

Hot And Cold Therapy Packs Market

Mannequin-Based Simulation Market

3D Ultrasound Market

Frequently Asked Questions

The Minimally Invasive Surgery Market size is estimated to be valued at USD 89,393.7 Mn in 2025, and is expected to reach USD 1,85,595.6 Mn by 2032.

The CAGR of the global Market is projected to be 11% from 2025 to 2032.

Increasing prevalence of orthopedic diseases is expected to drive the market growth.

Surgical devices is the leading device type segment in the market.

Disadvantages associated with minimally invasive surgery is expected to hinder the market growth over the forecast period.

Major players operating in the market include Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, Integrated Endoscopy